Contact Supplier

Contact Supplier

To get in touch with SIRION Biotech GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting

    SIRION Biotech GmbH News Releases

    Find the latest News from SIRION Biotech GmbH

    Page 1 of 4
    SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting
    SIRION Biotech to present insights on single cell level gene delivery to ASGCT 25th Anniversary Meeting Learn More >
    SIRION Biotech achieves ISO-9001:2015 Certification
    SIRION Biotech achieves ISO-9001:2015 Certification Learn More >
    SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies
    SIRION teams with Centre for Genomic Regulation to develop NextGen AAV vectors for diabetes gene therapies Learn More >
    PerkinElmer agrees to acquire SIRION Biotech
    PerkinElmer agrees to acquire SIRION Biotech Learn More >
    SIRION Biotech scoops double GHP Biotechnology Awards for 2021
    SIRION Biotech scoops double GHP Biotechnology Awards for 2021 Learn More >
    SIRION Biotech to collaborate with Sanofi on improved AAV capsids
    SIRION Biotech to collaborate with Sanofi on improved AAV capsids Learn More >
    Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”)
    Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the Treatment of X-linked Severe Combined Immunodeficiency (“XSCID”) Learn More >
    SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis
    SIRION Biotech GmbH licensed its LentiBOOST™ transduction technology to Cellectis Learn More >
    SIRION brings viral vector expertise to BioFIT 2020 virtual event
    SIRION brings viral vector expertise to BioFIT 2020 virtual event Learn More >
    SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy
    SIRION Biotech licenses LentiBOOST™ Technology to Mustang Bio for development of XSCID gene therapy Learn More >
    Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses
    Bavaria supports SIRION in development of AAV-delivered protective antibodies against coronaviruses Learn More >
    SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020
    SIRION Biotech defies COVID-19 to achieve 26% growth for first half 2020 Learn More >
    Page 1 of 4